The family plans to sell its pharmacies following a ‘strategic review’ by the shareholders
The property advisor, Christie & Co., confirmed the sale of the well-established North England pharmacy chain owned by Whitworth Chemists.
It has been in operation since 1999, and the sale is accessible through a dedicated project data known as Project Thorpe.
The company, headquartered in Scunthorpe, North Lincolnshire, offers centralized services and MHRA-approved warehousing facilities which are also available for sale.
Christie &Co. has labelled the sale as an opportunity which “does not come on the market often.”
Jay Badenhorst, the managing director at Whitworth Chemists Limited, and Superintendent Pharmacist, said: “Whitworth Chemists Limited has built a strong business over the last three decades, delivering a range of quality pharmacy services to a wide patient group across the North of England.
The pharmacy stretches from “Blackpool in the West to Skegness in the East, and up to Newcastle in the North East.”
Badenhorst said that the “business benefits from an amazing, dedicated team delivering first-class pharmacy services daily.”
It dispensed 8,500 items per month with volumes ranging from 3,000 items to 22,000 items.
He further added: “However, the time has come for the family shareholders to step back from the business, thereby offering a great opportunity for a new purchaser or purchasers to continue to build on the enviable reputation we have created.”
Jon Booth, the director of pharmacy at Christie & Co, who is handling the sale, said: “We are delighted to have been engaged by the family and shareholders of Whitworth Chemists Limited in this exciting project.
“Rarely does a group of this size and quality come to market and be offered for sale on a group, subgroup, or individual pharmacy basis, and we expect significant interest to be generated for the pharmacies.”
